jbi-802
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 8, 2022 (NCT05268666)
Timeline
Indications
Mechanism of action
- Histone deacetylase 6ANTAGONIST
HDAC6
Chemistry & pharmacology
Loading structure…
SMILES
Br.O=C(NO)c1ccc(Cn2cc(CN[C@@H]3C[C@H]3c3ccccc3)cn2)cc1- Mol. weight
- 443.35 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314919 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07207395 | Phase 2 | Apr 29, 2025 | The Christ Hospital |
| NCT05268666 | Phase 1/Phase 2 (Phase 2) | Apr 8, 2022 | Jubilant DraxImage Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jubilant DraxImage Inc. | For profit | 1 | 1 | 1 | 2022 |
| The Christ Hospital | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1